Results 221 to 230 of about 322,632 (326)

Patient Characteristics, Disease Profile and Treatment Patterns in Mild and Moderate Psoriasis Patients: Results From Real‐World Clinical Practices in Five European Countries (PROSPECT Study)

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Categorisation of psoriasis (PsO) disease severity in patients varies, although body surface area (BSA) affected is commonly used (< 3% ‘mild’, 3%–10% ‘moderate’ and > 10% ‘severe’). While moderate‐severe PsO has been well‐studied, more limited information regarding mild‐to‐moderate PsO is available.
Emily Goddard, Aaron Keal, James Hetherington, Sophie Barlow, David Wu, Melany Worbes‐Cerezo, Alexander Litvintchouk   +6 more
wiley   +1 more source

Systemic psoriasis therapy shows high between-country variation: a sign of unwarranted variation? Cross-sectional analysis of baseline data from the PSONET registries

, 2013
I. García‐Doval, Stephan Jeff Rustenbach, Robert S. Stern, T.N. Dam, Arnon D. Cohen, Christopher Baker, Phyllis I. Spuls, Luigi Naldi   +7 more
openalex   +2 more sources

To Explore the Mechanism of Cuproptosis in Psoriasis Based on Bioinformatics and in vivo Experiments. [PDF]

J Inflamm Res
Ma Y, Sun Y, Yao J, Zhang J, Wang H, Yang S.   +5 more
europepmc   +1 more source

Treating to Target in Hidradenitis Suppurativa: Canadian Perspectives

JEADV Clinical Practice, EarlyView.
Wayne Gulliver, Irina Turchin, Tracey Brown‐Maher, Marni Wiseman, Lauren Lam, Jessica Asgarpour, Raed Alhusayen   +6 more
wiley   +1 more source

Concurrent Psoriasis and Dermatomyositis: Retrospective Analysis and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Psoriasis (PsO) and dermatomyositis (DM) are both autoimmune‐mediated, inflammatory conditions. The concurrence of PsO and DM is rare, and literature on their relationship remains limited. Additionally, cutaneous DM can be challenging to clinically diagnosis, often presenting with psoriasiform clinical features.
Emily R. Gordon, Karishma S. Shah, Sidharth Chand, Bonnie Lee, Janellen Smith, Michelle S. Min   +5 more
wiley   +1 more source

Dramatic clearance of extensive psoriasis in a pediatric patient treated with upadacitinib: A case report. [PDF]

SAGE Open Med Case Rep
Mistry J, Moshkovich M, Sauder M, Sibbald C.   +3 more
europepmc   +1 more source

Assessing the Effect of Adalimumab in Granuloma Annulare: A Case Series and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Granuloma annulare (GA) is a benign granulomatous skin disorder for which standardized treatment guidelines are lacking due to limited evidence. Adalimumab, a TNF‐α inhibitor, shows promise as a therapeutic option due to its potential to disrupt GA granulomas.
Adriana Caixinha Valorenzos, Line Kibsgaard, Trine Bertelsen   +2 more
wiley   +1 more source

Metabolic Changes and Serum Ghrelin Level in Patients with Psoriasis

, 2014
Haydar Uçak, Betül Demir, Demet Çiçek, İlker Erden, Süleyman Aydın, Selma Bakar Dertlioğlu, Mustafa Arıca   +6 more
openalex   +1 more source

Causal Association Between Psoriasis and Age-Related Macular Degeneration: A Two-Sample Mendelian Randomization Study. [PDF]

Genes (Basel)
Lee Y, Kim S, Seo JH.
europepmc   +1 more source

Clinical Efficacy and Safety of Topical Roflumilast in Psoriasis: An Updated Systematic Review and Meta‐Analysis of Randomized Controlled Trials

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Traditional first‐line topical treatments for plaque psoriasis, particularly corticosteroids and vitamin D analogs, frequently have only limited efficacy for long‐term use, and present difficulties with safety and adherence. Objectives In this systematic review and meta‐analysis of randomized controlled trials (RCTs), we assessed ...
Aimal A. Khattak, Ahmed Javed, Ummi Aiman Rahman, Rumaisa Riaz, Zeeshan Imtiaz, Hassan A. Mirza, Farman U. Khan, Muhid Khattak, Fatima Javid, Abdul Moiz Khan, Adeline L. Roy, Bibek Shrestha   +11 more
wiley   +1 more source